The present invention includes pourable, non-toxic lubricating compositions containing carrageenan and more precisely λ carrageenan as an anti-viral agent, for protection from Human Papillomavirus (HPV), and methods of using the lubricating compositions as a non-oily, pseudoplastic lubrication product and administering the carrageenan for reducing the propagation of HPV during sexual activity.

The present invention relates to a UV blocking composition comprising red algae-derived floridoside and an amine group-containing compound, and a use thereof in a cosmetic material and a pharmaceutical composition.

The present invention relates to a seaweed-based composition comprising water, a seaweed powder and an additional component, said additional component being chosen from the group consisting of glucomannans, galactomannans, native starch and combinations thereof. Preferably, the red seaweed selected from the families of Gigartinaceae, Bangiophyceae, Palmariaceae, Hypneaceae, Cystocloniaceae, Solieriaceae, Phyllophoraceae and Furcellariaceae or combinations thereof.

The present invention relates to a seaweed-based composition comprising water, a seaweed powder and an additional component, said additional component being chosen from the group consisting of glucomannans, galactomannans, native starch and combinations thereof. Preferably, the red seaweed selected from the families of Gigartinaceae, Bangiophyceae, Palmariaceae, Hypneaceae, Cystocloniaceae, Solieriaceae, Phyllophoraceae and Furcellariaceae or combinations thereof.

The present invention relates to a method of increasing a measure of a production trait in a non-ruminant animal by administering a red seaweed of Asparagopsis species to the animal.

The present invention relates to a method of increasing a measure of a production trait in a non-ruminant animal by administering a red seaweed of Asparagopsis species to the animal.

The subject invention relates to a novel composition for the treatment of developmental bone diseases, and other related ailments in a subject using a composition comprising an algae extract and at least one strontium salt. The subject invention also relates to two compositions for the treatment of developmental bone diseases and other related ailments in a subject by administering a composition comprising a non-viable algal culture or an extract thereof and a second composition comprising at least one strontium salt. The algae extract can comprise calcium carbonate and magnesium carbonate.

The subject invention relates to a novel composition for the treatment of developmental bone diseases, and other related ailments in a subject using a composition comprising an algae extract and at least one strontium salt. The subject invention also relates to two compositions for the treatment of developmental bone diseases and other related ailments in a subject by administering a composition comprising a non-viable algal culture or an extract thereof and a second composition comprising at least one strontium salt. The algae extract can comprise calcium carbonate and magnesium carbonate.

The subject invention relates to a novel composition for the treatment of developmental bone diseases, and other related ailments in a subject using a composition comprising an algae extract and at least one strontium salt. The subject invention also relates to two compositions for the treatment of developmental bone diseases and other related ailments in a subject by administering a composition comprising a non-viable algal culture or an extract thereof and a second composition comprising at least one strontium salt. The algae extract can comprise calcium carbonate and magnesium carbonate.

A method of treating vaginal dryness by administering a vaginal care composition, which includes an effective amount of a vaginal care agent, to vaginal tissue of a user experiencing vaginal dryness. The vaginal care agent may be selected to specifically treat symptoms of vaginal dryness exhibited by the introitus and/or labia, based on the transcriptomic data of skin cells obtained therefrom. In some instances, the vaginal care composition may be applied to introitus and/or labia with a suitable implement configured for such use.